Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China

• Chaoneng He ,

  Contributed equally to this work with: Chaoneng He, Xiufang Mi

  Roles Conceptualization, Data curation, Funding acquisition, Methodology, Writing – original draft

  Affiliations School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China, Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

  ⨯
• Xiufang Mi ,

  Contributed equally to this work with: Chaoneng He, Xiufang Mi

  Roles Writing – original draft

  Affiliation Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

  ⨯
• Gaoqi Xu,

  Roles Data curation

  Affiliation Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

  ⨯
• Xinglu Xu,

  Roles Methodology

  Affiliation Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

  ⨯
• Wenxiu Xin,

  Roles Supervision

  Affiliation Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

  ⨯
• Like Zhong,

  Roles Formal analysis

  Affiliation Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

  ⨯
• Junfeng Zhu,

  Roles Formal analysis

  Affiliation Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

  ⨯
• Qi Shu,

  Roles Formal analysis

  Affiliation Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

  ⨯
• Luo Fang ,

  Roles Conceptualization, Supervision, Writing – review & editing

  * E-mail: dinghy@zjcc.org.cn (HD); fangluo@zjcc.org.cn (LF)

  Affiliation Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

  ⨯
• Haiying Ding

  Roles Conceptualization, Data curation, Writing – review & editing

  * E-mail: dinghy@zjcc.org.cn (HD); fangluo@zjcc.org.cn (LF)

  Affiliations Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

  https://orcid.org/0000-0003-4896-3976

  ⨯